The RiHN invites members to discuss the particular challenges and opportunities that RDM offers, particularly point of care manufacturing. Having previously identified the four major technology themes that offer the best benefit to healthcare, we now turn our attention to how manufacturing at the point of care redefines the business case and the operational requirements to do so. We intend to support the talks with insight from member polls, our steering board, major stakeholders and champions for RDM.
Our next event will be Clinical Fluids, and Cell and Tissue Manufacturing on Tuesday 7 December 2021 from 9:30am to 12:00pm which will be held online.
Speakers confirmed so far;
Prof. Darren Reynolds, UWE Bristol – Darren is lead PI for one of the RiHN feasibility studies, developing clinical-grade water at the point of need. The technology is being developed with a number of partners and with support for field testing from humanitarian organisations.
Date: 07 December 2021
Time: 09:30 – 12:00 GMT